WEBB, III v. DIVERSEGY, LLC

District Court, D. New Jersey·Decided August 21, 2025·No. 2:21-cv-12088·Unknown

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

JOHNNY E. WEBB III, Plaintiff, Civil No.: 21-12088 v. OPINION & ORDER

DIVERSEGY, LLC, DOMINION GAS HOLDINGS, LP, IDT ENERGY, INC., GENIE ENERGY SERVICES, LLC, f/k/a SHUK HOLDINGS LLC, LUCIEN J. TUJAGUE, JR., ALEX RODRIGUEZ, SAMIR AKHTARKHAVARI a/k/a SAM KHAVARI, and JOHN DOES,

Defendants.

CECCHI, District Judge. Before the Court are three motions to dismiss Plaintiff’s Amended Complaint (ECF No. 92, “FAC”) pursuant to Federal Rule of Civil Procedure 12(b)(6) filed by defendants Samir Akhtarkhavari a/k/a Sam Khavari (“Khavari”) (ECF No. 93), Dominion Gas Holdings, LP (“Dominion”) and Lucien J. Tujague, Jr. (“Tujague”) (ECF No. 103), and Diversegy, LLC (“Diversegy”), Genie Energy Services, LLC (“Genie”), and IDT Energy, Inc. (“IDT”) (ECF No. 104) (together, “Defendants”), a motion to strike filed by Diversegy, Genie, and IDT pursuant to Federal Rule of Civil Procedure 12(f) (ECF No. 105), and a motion for default judgment as to Alex Rodriguez (“Rodriguez”) filed by Plaintiff (ECF No. 147). Plaintiff opposed Defendants’ motions. ECF No. 113-2, 113-3, 113-7. Defendants replied in support of their motions. ECF Nos. 127, 128, 129. Plaintiff filed a sur-reply (ECF No. 137), and Defendants filed responses to Plaintiff’s sur-reply (ECF Nos. 138, 139. 140). The Court decides this matter without oral argument pursuant to Federal Rule of Civil Procedure 78(b). For the reasons set forth below, Defendants’ motions are GRANTED and Plaintiff’s FAC is dismissed without prejudice to refile in the Superior Court of New Jersey, Essex County. I. BACKGROUND

This case arises from the sale of Diversegy, an energy brokerage and advisory company. FAC ¶ 56. Plaintiff was a founding member of Diversegy and held the position of Vice President of Sales and Marketing. Id. ¶ 57. On December 5, 2013, Diversegy entered into a Unit Purchase Agreement (“UPA”) with Shuk Holdings LLC (“Shuk”)—which later became Genie—and IDT (together, the “Buyers”) to purchase all membership interests of Diversegy. Id. ¶¶ 78–80; see also ECF No. 104-3. Plaintiff claims that he was never told about the deal, and that his signature on the UPA was forged. Id. ¶¶ 81–82. He further complains that Diversegy failed to pay him his ownership interest from the sale or commission payments he earned prior to the sale, and that Diversegy misrepresented the value of the company. Id. ¶¶ 64–66, 83. Since the UPA was executed, Plaintiff has filed two lawsuits in Texas state courts against

various parties involved in the sale, including Defendants in the instant matter. See id. ¶¶ 89–100, 117–127. In the first lawsuit, filed on August 27, 2014 (the “August 2014 Petition”), the trial court held that the UPA was enforceable as to Plaintiff, and dismissed Plaintiff’s case without prejudice because of the UPA’s forum selection clause, which designates “the state or federal courts in Essex County, New Jersey” as the “exclusive jurisdiction” for any actions arising out of or relating to the UPA. Id. ¶ 121; ECF No. 104-3; Webb v. Rodriguez, No. 06-14-00102-CV, 2015 WL 3486175, at *3 (Tex. App. June 3, 2015). The Texas Court of Appeals affirmed the trial court’s decision. FAC ¶ 100; Webb, 2015 WL 3486175, at *3. In the second lawsuit, the Texas trial court once again dismissed Plaintiff’s case without prejudice to filing in the appropriate forum in New Jersey, and the court of appeals affirmed, citing collateral estoppel. See Webb v. Diversegy, LLC, No. 05- 17-01258-CV, 2019 WL 1146707, at *5, 7 (Tex. App. Mar. 13, 2019). Plaintiff now brings this action, which also alleges misconduct arising from the sale of Diversegy. II. LEGAL STANDARD

To survive dismissal under Rule 12(b)(6), a complaint must meet the pleading requirements of Rule 8(a)(2) and “contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (citation omitted). In evaluating the sufficiency of a complaint, a court must “draw all reasonable inferences in favor of the non-moving party.” Phillips v. Cnty. of Allegheny, 515 F.3d 224, 231 (3d Cir. 2008) (citation omitted). Ultimately, a complaint “that offers ‘labels and conclusions’ or . . . tenders ‘naked assertions’ devoid of ‘further factual enhancement,’” will not withstand dismissal. Iqbal, 556 U.S. at 678 (citations and brackets omitted). III. DISCUSSION Plaintiff alleges violations of the Securities Exchange Act, 15 U.S.C. § 78j(b) and 17

C.F.R. § 240.10b-5, as well as other unspecified securities and antitrust laws against all Defendants. Plaintiff also asserts numerous state law claims. As discussed below, Plaintiff’s federal claims are barred by the applicable statute of limitations and statute of repose, and the Court declines to exercise supplemental jurisdiction over Plaintiff’s state law claims. A. Statutes of Limitations and Repose1 Plaintiff’s federal law claims—violations of section 10(b) of the Securities Exchange Act, 15 U.S.C.S. §§ 78j(b), and 17 C.F.R. § 240.10b-5 (Counts A and L)—are time-barred.2 Section 10(b) and Rule 10b-5 claims are subject to a statute of limitations and a statute of

repose. See 28 U.S.C. § 1658; see also Aly v. Valeant Pharms. Int’l Inc., 1 F.4th 168, 171 (3d Cir. 2021) (“[C]laims under Section 10(b) [and] Rule 10b-5 . . . [are] subject to the same two-year limitations and five-year repose periods.”). As discussed below, Plaintiff’s securities fraud claims are barred by both. 1. Statute of Limitations The statute of limitations requires securities fraud claims to be “brought within ‘2 years after the discovery of the facts constituting the violation.’” Aly, 1 F.4th at 171 n.12 (quoting 28 U.S.C. § 1658(b)). The limitations period “begins to run once the plaintiff did discover or a reasonably diligent plaintiff would have ‘discover[ed] the facts constituting the violation’—whichever comes first.” Catalyst Dynamic Alpha Fund v. Valeant Pharms. Int’l,

Inc., No. 18-12673, 2019 WL 2331631, at *4 (D.N.J. May 31, 2019) (quoting Merck & Co. v. Reynolds, 559 U.S. 633, 653 (2010)).

Free access — add to your briefcase to read the full text and ask questions with AI

WEBB, III v. DIVERSEGY, LLC, (D.N.J. 2025).

WEBB, III v. DIVERSEGY, LLC (WEBB, III v. DIVERSEGY, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Carden v. Arkoma Associates
494 U.S. 185 (Supreme Court, 1990)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Kurt Danysh v. Eli Lilly Co
461 F. App'x 75 (Third Circuit, 2012)
Glenda Johnson v. SmithKline Beecham Corp
724 F.3d 337 (Third Circuit, 2013)
In Re Exxon Mobil Corp. Securities Litigation
500 F.3d 189 (Third Circuit, 2007)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Freeman v. State
788 A.2d 867 (New Jersey Superior Court App Division, 2002)
In Re Exxon Mobil Corp. Securities Litigation
387 F. Supp. 2d 407 (D. New Jersey, 2005)
Lincoln Benefit Life Co. v. AEI Life, LLC
800 F.3d 99 (Third Circuit, 2015)
GBForefront LP v. Forefront Management Group LLC
888 F.3d 29 (Third Circuit, 2018)
Bahaa Aly v. Valeant Pharmaceuticals Inter
1 F.4th 168 (Third Circuit, 2021)